UK Member of EU Parliament says India withdrew invitation to visit Kashmir

Agencies
October 29, 2019

A senior UK politician claimed on Tuesday that the Indian government withdrew with little explanation its invitation to him to be part of an EU delegation currently on a visit to Kashmir after he demanded to speak with local people without a police escort.

Liberal Democrat Member of the European Parliament (MEP) Chris Davies said the decision showed the Indian government was trying to hide the "reality of its actions" and blocking absolute freedom of the press.

"I am not prepared to take part in a PR stunt for the Modi government and pretend that all is well. It is very clear that democratic principles are being subverted in Kashmir, and the world needs to start taking notice," said Davies, whose invite for the visit between October 27 and 30 was reportedly rescinded.

A delegation of 23 MPs from the European Union reached Srinagar on Tuesday for a two-day visit during which they will be briefed on the situation by government officials and also meet a cross-section of local people.

The team originally comprised 27 parliamentarians, mostly from extreme right or right wing parties, but four did not travel to Kashmir and have reportedly returned to their respective countries, officials said.

On Monday, the members of the European Parliament met Prime Minister Narendra Modi in Delhi during which he expressed hope that they have a fruitful visit to various parts of the country, including to Jammu and Kashmir.

"Their visit to Jammu and Kashmir should give the delegation a better understanding of the cultural and religious diversity of the region of Jammu, Kashmir and Ladakh, apart from giving them a clear view of the development and government priorities of the region," a statement from the Prime Minister's Office said.

Davies, who represents his UK constituents from the north-west of England in the EU Parliament, was reportedly invited by the Indian officials to visit Jammu and Kashmir two months after the government revoked Article 370 in the region to bring it in line with the rest of the country.

But Davies claims the invitation was "promptly withdrawn with little explanation" after he insisted he must be free to talk with local people, unaccompanied by police or security forces, and invite journalists without interrogation.

"What is it that the Indian government has to hide? Why will it not give journalists and visiting politicians free access to speak with local people? I represent thousands of people in the North West of England who have family associations with Kashmir. They want to be able to speak freely to their relatives. They want their voices to be heard," he said.

"I fear that this is not going to end well. Governments do not win the hearts and minds of people by taking away their freedoms and imposing military rule. The risk of a violent backlash is all too evident," Davies said.

His office said that the MEP would like to visit the region at a future date as he represents the North West of England, which has thousands of constituents of Kashmiri heritage with many having relatives in Kashmir. "Communication difficulties with families is just as one of the issues that has been raised with him," a spokesperson said.

The EU delegation's visit is the first India has allowed for a foreign delegation to the Valley since August 5 when Jammu and Kashmir's special status was revoked by the Indian government.

India has categorically told the international community that the scrapping of Article 370 was an internal matter.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 10,2020

Paris, Apr 10: French pharma major Sanofi said on Friday it has decided to donate 100 million doses of hydroxychloroquine, the anti-malaria drug which could be a potential weapon against novel coronavirus, across 50 countries.

The company has already doubled its incremental production capacity on top of the usual production for current indications across its eight hydroxychloroquine manufacturing sites worldwide and is on track to quadruple it by the summer.

"In this global health emergency, Sanofi stands ready to assist as many countries as possible, starting with countries where its medicine is registered for current approved indications as well as countries where there are no hydroxychloroquine suppliers or countries with underserved populations," it said in a statement.

Sanofi called for coordination among the entire hydroxychloroquine chain worldwide to ensure the continued supply of the medicine if proven to be a well-tolerated and effective treatment in COVID-19 patients.

"The COVID-19 pandemic is an unprecedented health and economic crisis which is shaking some of the very fundamentals of international solidarity and cooperation among countries," said Chief Executive Officer Paul Hudson. "This virus does not care about the concept of borders, so we should not either," he added.

"It is critical that international authorities, local governments, manufacturers and all other players involved in the hydroxychloroquine chain work together in a coordinated manner to ensure all patients who may benefit from this potential treatment can access it. If the trials prove positive, we hope our donation will play a critical role for patients," said Hudson.

While hydroxychloroquine is generating a lot of hope for patients around the world, said Sanofi, it should be remembered that there are no results from ongoing studies and the results may be positive or negative.

To date, there is insufficient clinical evidence to draw any conclusion over the safety and efficacy of hydroxychloroquine in the management of COVID-19 patients.

It is one of several medicines being investigated by the World Health Organisation (WHO) in its international clinical trial seeking a treatment solution for COVID-19. "Sanofi is supporting ongoing trials by providing the medicine to some participating investigator sites and other independent research centres," it said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 18,2020

Washington, May 18: US President Donald Trump on Sunday called his predecessor Barak Obama a ‘grossly incompetent president’.

The Trump’s reaction came after Obama on Saturday criticised the US authorities' response to the coronavirus outbreak.

“He (Obama) was an incompetent president. That’s all I can say. Grossly incompetent,” Trump told reporters at the White House on his arrival from Camp David.

Trump was responding to a question on the virtual commencement address by Obama a day earlier.

In his address to college graduates, Obama had said that the COVID-19 pandemic has exposed the American leadership.

“More than anything, this pandemic has fully, finally torn back the curtain on the idea that so many of the folks in charge know what they’re doing,” Obama said without naming officials.

“A lot of them aren’t even pretending to be in charge,” he added.

There was no immediate response from the office of the former president on the remarks made by Trump.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 26,2020

Scientists predict the world may have a COVID-19 vaccine within one year or even a few months earlier, said the Director-General of the World Health Organisation even as he underlined the importance of global cooperation to develop, manufacture and distribute vaccines.

However, making the vaccine available and distributing it to all will be a challenge and requires political will, Tedros Adhanom Ghebreyesus said on Thursday during a meeting with the European Parliament's Committee for Environment, Public Health and Food Safety.

One option would be to give the vaccine only to those that are most vulnerable to the virus.

There are currently over 100 COVID-19 vaccine candidates in various stages of development.

Adhanom Ghebreyesus said the pandemic has highlighted the importance of global solidarity and that health should not be seen as a cost but an investment.

He added that all countries in the world must strengthen primary health care and crisis preparedness and stressed the need for EU leadership globally.

While the Director-General said the situation in the EU has improved significantly, he underlined that COVID-19 is very much still circulating globally, with more than four million new cases in the last month.

Many Members of European Parliament said that the global community must cooperate including in developing, manufacturing and distributing vaccines against COVID-19 and asked when a safe vaccine could be available.

Several Members of European Parliament underlined the importance of the WHO but also said it has made mistakes in its response to the pandemic.

The Director-General admitted everyone makes mistakes and informed the members that an independent panel will evaluate the WHO response to the pandemic to learn from any mistakes made.

It will start its work soon, he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.